Evidence map›Paper›PMID 42164822›Full record

ArticleFrontiers in fungal biology2026

Clinical

Kai-Su Pan, Siwen Jiang, Dong-Yan Zheng, Yan-Qing Zheng, Wei-Xuan Wu, Cun-Wei Cao

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in fungal biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Kai-Su Pan *Department of Dermatology and Venereology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.
Siwen Jiang *Department of Dermatology and Venereology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.
Dong-Yan ZhengDepartment of Dermatology and Venereology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.
Yan-Qing ZhengGuangxi Key Laboratory of Mycosis Research and Prevention, Nanning, China.
Wei-Xuan WuDepartment of Dermatology and Venereology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.
Cun-Wei CaoDepartment of Dermatology and Venereology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Talaromycosis, caused by the dimorphic fungus Methods: A total of 196 Results: Azole antifungals (itraconazole, voriconazole, posaconazole) exhibited low MICs, indicating strong activity; Clinical strains showed higher geometric mean MICs for most antifungals than non-clinical strains. Non-clinical strains showed significantly less adaptability to stress than clinical strains under CR, H Discussion: These findings suggest that non-clinical strains may undergo phenotypic adaptations when infecting human hosts, enhancing their resilience to environmental factors and immune pressures. Antifungal susceptibility was not associated with HIV status or patient age, but linked to host adaptation.

Indexed as

antifungalclinical strainsHIVnon-clinical strainsTalaromyces marneffeitalaromycosis

Identifiers

PMID42164822
PMCPMC13183614

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.